$246.22
Add to Cart
Aloe-emodin98%
5 available
Details
Shipping: Australia: free (more destinations)
Condition: Brand new
*The store has not been updated recently. You may want to contact the merchant to confirm the availability of the product.
assay more then 98%.
Price is 176$ per g, it is only for goods, no included freight.
Also, we will send the COA in the packing. If your test is no good for the COA, we accept the goods.
CAS #: 481-72-1
Molecular formula: C15H10O5
Molecular weight: 270.24
Formulation: White powder
Purity: 98%
aloe-emodin (AE), a hydroxyanthraquinone present in Aloe vera leaves, has a specific in vitro and in vivo antineuroectodermal tumor activity. The growth of human neuroectodermal tumors is inhibited in mice with severe combined immunodeficiency without any appreciable toxic effects on the animals. The compound does not inhibit the proliferation of normal fibroblasts nor that of hemopoietic progenitor cells. The cytotoxicity mechanism consists of the induction of apoptosis, whereas the selectivity against neuroectodermal tumor cells is founded on a specific energy-dependent pathway of drug incorporation. Taking into account its unique cytotoxicity profile and mode of action, AE might represent a conceptually new lead antitumor drug.
Price is 176$ per g, it is only for goods, no included freight.
Also, we will send the COA in the packing. If your test is no good for the COA, we accept the goods.
CAS #: 481-72-1
Molecular formula: C15H10O5
Molecular weight: 270.24
Formulation: White powder
Purity: 98%
aloe-emodin (AE), a hydroxyanthraquinone present in Aloe vera leaves, has a specific in vitro and in vivo antineuroectodermal tumor activity. The growth of human neuroectodermal tumors is inhibited in mice with severe combined immunodeficiency without any appreciable toxic effects on the animals. The compound does not inhibit the proliferation of normal fibroblasts nor that of hemopoietic progenitor cells. The cytotoxicity mechanism consists of the induction of apoptosis, whereas the selectivity against neuroectodermal tumor cells is founded on a specific energy-dependent pathway of drug incorporation. Taking into account its unique cytotoxicity profile and mode of action, AE might represent a conceptually new lead antitumor drug.
CN, Shannxi
